Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Kidney Journal
Published September 1, 2026
Continuation of sodium-glucose co-transporter 2 inhibitors in advanced chronic kidney disease: a ...
September 6, 2026
Medspoke
Medspoke
Nephrology Dialysis Transplantation (NDT)
Published September 4, 2026
00:00
--:--
CKD risk with tegoprazan versus proton pump inhibitors.
September 5, 2026
Share
CKD risk with tegoprazan versus proton pump inhibitors.
https://www.medspoke.co/channel_journal?id=797&tap_id=13666
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Nephrology Dialysis Transplantation (NDT)
Published September 4, 2026
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDEN...
September 5, 2026
Why are you reporting this TALK?
